the purging procedure appears acceptable for clinical marrow purging prior to cyropreservation and autotransplantation in patients with documented bm involvement of neoplastic cells sensitive to 4hc with positive binding to sba such as breast cancer .
C0597032
neoplastic
C0006142
breast cancer